Alnylam Pharmaceuticals
ALNY
#640
Rank
NZ$54.40 B
Marketcap
$421.81
Share price
-0.59%
Change (1 day)
41.34%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of September 2024 : NZ$4.80 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has NZ$4.80 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$3.85 B11.7%
2022-12-31NZ$3.45 B-3.16%
2021-12-31NZ$3.56 B37.26%
2020-12-31NZ$2.59 B13.89%
2019-12-31NZ$2.28 B41.12%
2018-12-31NZ$1.61 B-32.1%
2017-12-31NZ$2.38 B163.07%
2016-12-31NZ$0.90 B-42.68%
2015-12-31NZ$1.57 B77.55%
2014-12-31NZ$0.88 B197.19%
2013-12-31NZ$0.29 B100.41%
2012-12-31NZ$0.14 B-20.41%
2011-12-31NZ$0.18 B-37.92%
2010-12-31NZ$0.30 B-22%
2009-12-31NZ$0.38 B-47.76%
2008-12-31NZ$0.74 B45.68%
2007-12-31NZ$0.50 B65.08%
2006-12-31NZ$0.30 B163.47%
2005-12-31NZ$0.11 B81.38%
2004-12-31NZ$64.53 M80.87%
2003-12-31NZ$35.67 M20.65%
2002-12-31NZ$29.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.17 B-75.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.93 B 252.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.07 B-56.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.70 B-85.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B-96.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$24.23 B 404.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$12.59 B 162.00%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$5.73 B 19.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel